Cardinal Health Buys Diabetes and Home Care Assets in a $360 Million Push Into At‑Home Chronic Care
Cardinal Health (NYSE: CAH) will acquire AdaptHealth’s diabetes health business and multi‑specialty supply company Strive Medical in two separate transactions, totaling about $360 million. AdaptHealth disclosed that the diabetes unit is being sold for $235 million, implying roughly $125 million for Strive Medical. Cardinal has not provided a specific closing date, but the company expects both deals to be accretive to earnings within 12 months of completion.
Strategic fit for at‑home care
Both acquisitions will fold into Cardinal’s at‑Home Solutions segment, which focuses on delivering medical supplies and services directly to patients in their homes. The diabetes health business strengthens Cardinal’s presence in glucose monitoring and insulin‑related supplies, building on its earlier purchase of Advanced Diabetes Supply. Strive Medical, based in Texas, adds durable medical equipment and consumables in urology, wound care, ostomy and incontinence, broadening Cardinal’s at‑home product mix.
Why Cardinal is doing this
Cardinal is using these tuck‑in deals to expand its role in chronic care management outside the hospital. Home‑based diabetes and urology supplies are recurring, need‑driven categories, which can support steady revenue and deepen relationships with payers and providers. By bolstering at‑Home Solutions after the Advanced Diabetes Supply deal, Cardinal is positioning itself as a more comprehensive partner for health systems and insurers that want patients to manage conditions from home when possible.
Investor angle
For investors, the combined $360 million price tag looks aimed at scale and synergy rather than a single large flagship acquisition. If integration goes well, Cardinal should see higher at‑home volume, more cross‑selling across diabetes and urology categories, and incremental earnings uplift once the deals season. Key watchpoints will be execution on integration, margin performance in the at‑home segment, and how effectively Cardinal uses these assets to grow
